טוען...
Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
BACKGROUND: Antiarrhythmic action of flecainide is based on sodium channel blockade. Beta(1)-adrenoceptor (β(1)AR) activation induces sodium channel inhibition, too. The aim of the present study was to evaluate the impact of different β(1)AR genotypes on antiarrhythmic action of flecainide in patien...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2896398/ https://ncbi.nlm.nih.gov/pubmed/20625396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0011421 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|